Global Genetically Engineered Vector Vaccine Supply, Demand and Key Producers, 2024-2030
The global Genetically Engineered Vector Vaccine market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
A genetically engineered vector vaccine is a type of vaccine that uses a viral vector that has been genetically modified to carry and express genes encoding antigens from a pathogen, such as a virus or bacterium. This approach is part of the broader field of genetic engineering in vaccinology and is designed to stimulate an immune response against the target pathogen.
This report studies the global Genetically Engineered Vector Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Genetically Engineered Vector Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Genetically Engineered Vector Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Genetically Engineered Vector Vaccine total production and demand, 2019-2030, (K Units)
Global Genetically Engineered Vector Vaccine total production value, 2019-2030, (USD Million)
Global Genetically Engineered Vector Vaccine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Genetically Engineered Vector Vaccine consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Genetically Engineered Vector Vaccine domestic production, consumption, key domestic manufacturers and share
Global Genetically Engineered Vector Vaccine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Genetically Engineered Vector Vaccine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Genetically Engineered Vector Vaccine production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Genetically Engineered Vector Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Merck, GSK, Wantai Biotechnology, Watson Bio, Bharat Biotech, Sanofi, Zoties and Elanco, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Genetically Engineered Vector Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Genetically Engineered Vector Vaccine Market, By Region:
1. How big is the global Genetically Engineered Vector Vaccine market?
2. What is the demand of the global Genetically Engineered Vector Vaccine market?
3. What is the year over year growth of the global Genetically Engineered Vector Vaccine market?
4. What is the production and production value of the global Genetically Engineered Vector Vaccine market?
5. Who are the key producers in the global Genetically Engineered Vector Vaccine market?
A genetically engineered vector vaccine is a type of vaccine that uses a viral vector that has been genetically modified to carry and express genes encoding antigens from a pathogen, such as a virus or bacterium. This approach is part of the broader field of genetic engineering in vaccinology and is designed to stimulate an immune response against the target pathogen.
This report studies the global Genetically Engineered Vector Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Genetically Engineered Vector Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Genetically Engineered Vector Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Genetically Engineered Vector Vaccine total production and demand, 2019-2030, (K Units)
Global Genetically Engineered Vector Vaccine total production value, 2019-2030, (USD Million)
Global Genetically Engineered Vector Vaccine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Genetically Engineered Vector Vaccine consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Genetically Engineered Vector Vaccine domestic production, consumption, key domestic manufacturers and share
Global Genetically Engineered Vector Vaccine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Genetically Engineered Vector Vaccine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Genetically Engineered Vector Vaccine production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Genetically Engineered Vector Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Merck, GSK, Wantai Biotechnology, Watson Bio, Bharat Biotech, Sanofi, Zoties and Elanco, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Genetically Engineered Vector Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Genetically Engineered Vector Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Viral Vector Vaccine
- Plasmid Vector Vaccine
- VLPV
- RNA Vaccine
- Hospital
- Clinic
- Others
- Pfizer
- Merck
- GSK
- Wantai Biotechnology
- Watson Bio
- Bharat Biotech
- Sanofi
- Zoties
- Elanco
- Boehringer Ingelheim
- Indian Immunologicals
- Zhongmu Industrial Co., Ltd.
- Qingdao Yibang Bioengineering Co., Ltd.
- Jinyu Biotechnology
- Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences
- Tianjin Ruipu Biotechnology
- Kyoto Biken Laboratories
- FATRO
- Ceva Santй Animale
- Pleco
- Wuhan Huisheng Biotechnology
- Jinhe Biotechnology
- Shenlian Biotechnology
- Azure Creatures
1. How big is the global Genetically Engineered Vector Vaccine market?
2. What is the demand of the global Genetically Engineered Vector Vaccine market?
3. What is the year over year growth of the global Genetically Engineered Vector Vaccine market?
4. What is the production and production value of the global Genetically Engineered Vector Vaccine market?
5. Who are the key producers in the global Genetically Engineered Vector Vaccine market?
1 SUPPLY SUMMARY
1.1 Genetically Engineered Vector Vaccine Introduction
1.2 World Genetically Engineered Vector Vaccine Supply & Forecast
1.2.1 World Genetically Engineered Vector Vaccine Production Value (2019 & 2023 & 2030)
1.2.2 World Genetically Engineered Vector Vaccine Production (2019-2030)
1.2.3 World Genetically Engineered Vector Vaccine Pricing Trends (2019-2030)
1.3 World Genetically Engineered Vector Vaccine Production by Region (Based on Production Site)
1.3.1 World Genetically Engineered Vector Vaccine Production Value by Region (2019-2030)
1.3.2 World Genetically Engineered Vector Vaccine Production by Region (2019-2030)
1.3.3 World Genetically Engineered Vector Vaccine Average Price by Region (2019-2030)
1.3.4 North America Genetically Engineered Vector Vaccine Production (2019-2030)
1.3.5 Europe Genetically Engineered Vector Vaccine Production (2019-2030)
1.3.6 China Genetically Engineered Vector Vaccine Production (2019-2030)
1.3.7 Japan Genetically Engineered Vector Vaccine Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Genetically Engineered Vector Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Genetically Engineered Vector Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Genetically Engineered Vector Vaccine Demand (2019-2030)
2.2 World Genetically Engineered Vector Vaccine Consumption by Region
2.2.1 World Genetically Engineered Vector Vaccine Consumption by Region (2019-2024)
2.2.2 World Genetically Engineered Vector Vaccine Consumption Forecast by Region (2025-2030)
2.3 United States Genetically Engineered Vector Vaccine Consumption (2019-2030)
2.4 China Genetically Engineered Vector Vaccine Consumption (2019-2030)
2.5 Europe Genetically Engineered Vector Vaccine Consumption (2019-2030)
2.6 Japan Genetically Engineered Vector Vaccine Consumption (2019-2030)
2.7 South Korea Genetically Engineered Vector Vaccine Consumption (2019-2030)
2.8 ASEAN Genetically Engineered Vector Vaccine Consumption (2019-2030)
2.9 India Genetically Engineered Vector Vaccine Consumption (2019-2030)
3 WORLD GENETICALLY ENGINEERED VECTOR VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Genetically Engineered Vector Vaccine Production Value by Manufacturer (2019-2024)
3.2 World Genetically Engineered Vector Vaccine Production by Manufacturer (2019-2024)
3.3 World Genetically Engineered Vector Vaccine Average Price by Manufacturer (2019-2024)
3.4 Genetically Engineered Vector Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Genetically Engineered Vector Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Genetically Engineered Vector Vaccine in 2023
3.5.3 Global Concentration Ratios (CR8) for Genetically Engineered Vector Vaccine in 2023
3.6 Genetically Engineered Vector Vaccine Market: Overall Company Footprint Analysis
3.6.1 Genetically Engineered Vector Vaccine Market: Region Footprint
3.6.2 Genetically Engineered Vector Vaccine Market: Company Product Type Footprint
3.6.3 Genetically Engineered Vector Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Genetically Engineered Vector Vaccine Production Value Comparison
4.1.1 United States VS China: Genetically Engineered Vector Vaccine Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Genetically Engineered Vector Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Genetically Engineered Vector Vaccine Production Comparison
4.2.1 United States VS China: Genetically Engineered Vector Vaccine Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Genetically Engineered Vector Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Genetically Engineered Vector Vaccine Consumption Comparison
4.3.1 United States VS China: Genetically Engineered Vector Vaccine Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Genetically Engineered Vector Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Genetically Engineered Vector Vaccine Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Genetically Engineered Vector Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Genetically Engineered Vector Vaccine Production Value (2019-2024)
4.4.3 United States Based Manufacturers Genetically Engineered Vector Vaccine Production (2019-2024)
4.5 China Based Genetically Engineered Vector Vaccine Manufacturers and Market Share
4.5.1 China Based Genetically Engineered Vector Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Genetically Engineered Vector Vaccine Production Value (2019-2024)
4.5.3 China Based Manufacturers Genetically Engineered Vector Vaccine Production (2019-2024)
4.6 Rest of World Based Genetically Engineered Vector Vaccine Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Genetically Engineered Vector Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Genetically Engineered Vector Vaccine Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Genetically Engineered Vector Vaccine Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Genetically Engineered Vector Vaccine Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Viral Vector Vaccine
5.2.2 Plasmid Vector Vaccine
5.2.3 VLPV
5.2.4 RNA Vaccine
5.3 Market Segment by Type
5.3.1 World Genetically Engineered Vector Vaccine Production by Type (2019-2030)
5.3.2 World Genetically Engineered Vector Vaccine Production Value by Type (2019-2030)
5.3.3 World Genetically Engineered Vector Vaccine Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Genetically Engineered Vector Vaccine Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Genetically Engineered Vector Vaccine Production by Application (2019-2030)
6.3.2 World Genetically Engineered Vector Vaccine Production Value by Application (2019-2030)
6.3.3 World Genetically Engineered Vector Vaccine Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Genetically Engineered Vector Vaccine Product and Services
7.1.4 Pfizer Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck Genetically Engineered Vector Vaccine Product and Services
7.2.4 Merck Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Genetically Engineered Vector Vaccine Product and Services
7.3.4 GSK Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Wantai Biotechnology
7.4.1 Wantai Biotechnology Details
7.4.2 Wantai Biotechnology Major Business
7.4.3 Wantai Biotechnology Genetically Engineered Vector Vaccine Product and Services
7.4.4 Wantai Biotechnology Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Wantai Biotechnology Recent Developments/Updates
7.4.6 Wantai Biotechnology Competitive Strengths & Weaknesses
7.5 Watson Bio
7.5.1 Watson Bio Details
7.5.2 Watson Bio Major Business
7.5.3 Watson Bio Genetically Engineered Vector Vaccine Product and Services
7.5.4 Watson Bio Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Watson Bio Recent Developments/Updates
7.5.6 Watson Bio Competitive Strengths & Weaknesses
7.6 Bharat Biotech
7.6.1 Bharat Biotech Details
7.6.2 Bharat Biotech Major Business
7.6.3 Bharat Biotech Genetically Engineered Vector Vaccine Product and Services
7.6.4 Bharat Biotech Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Bharat Biotech Recent Developments/Updates
7.6.6 Bharat Biotech Competitive Strengths & Weaknesses
7.7 Sanofi
7.7.1 Sanofi Details
7.7.2 Sanofi Major Business
7.7.3 Sanofi Genetically Engineered Vector Vaccine Product and Services
7.7.4 Sanofi Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Sanofi Recent Developments/Updates
7.7.6 Sanofi Competitive Strengths & Weaknesses
7.8 Zoties
7.8.1 Zoties Details
7.8.2 Zoties Major Business
7.8.3 Zoties Genetically Engineered Vector Vaccine Product and Services
7.8.4 Zoties Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Zoties Recent Developments/Updates
7.8.6 Zoties Competitive Strengths & Weaknesses
7.9 Elanco
7.9.1 Elanco Details
7.9.2 Elanco Major Business
7.9.3 Elanco Genetically Engineered Vector Vaccine Product and Services
7.9.4 Elanco Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Elanco Recent Developments/Updates
7.9.6 Elanco Competitive Strengths & Weaknesses
7.10 Boehringer Ingelheim
7.10.1 Boehringer Ingelheim Details
7.10.2 Boehringer Ingelheim Major Business
7.10.3 Boehringer Ingelheim Genetically Engineered Vector Vaccine Product and Services
7.10.4 Boehringer Ingelheim Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Boehringer Ingelheim Recent Developments/Updates
7.10.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.11 Indian Immunologicals
7.11.1 Indian Immunologicals Details
7.11.2 Indian Immunologicals Major Business
7.11.3 Indian Immunologicals Genetically Engineered Vector Vaccine Product and Services
7.11.4 Indian Immunologicals Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Indian Immunologicals Recent Developments/Updates
7.11.6 Indian Immunologicals Competitive Strengths & Weaknesses
7.12 Zhongmu Industrial Co., Ltd.
7.12.1 Zhongmu Industrial Co., Ltd. Details
7.12.2 Zhongmu Industrial Co., Ltd. Major Business
7.12.3 Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Product and Services
7.12.4 Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Zhongmu Industrial Co., Ltd. Recent Developments/Updates
7.12.6 Zhongmu Industrial Co., Ltd. Competitive Strengths & Weaknesses
7.13 Qingdao Yibang Bioengineering Co., Ltd.
7.13.1 Qingdao Yibang Bioengineering Co., Ltd. Details
7.13.2 Qingdao Yibang Bioengineering Co., Ltd. Major Business
7.13.3 Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Product and Services
7.13.4 Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Qingdao Yibang Bioengineering Co., Ltd. Recent Developments/Updates
7.13.6 Qingdao Yibang Bioengineering Co., Ltd. Competitive Strengths & Weaknesses
7.14 Jinyu Biotechnology
7.14.1 Jinyu Biotechnology Details
7.14.2 Jinyu Biotechnology Major Business
7.14.3 Jinyu Biotechnology Genetically Engineered Vector Vaccine Product and Services
7.14.4 Jinyu Biotechnology Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Jinyu Biotechnology Recent Developments/Updates
7.14.6 Jinyu Biotechnology Competitive Strengths & Weaknesses
7.15 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences
7.15.1 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Details
7.15.2 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Major Business
7.15.3 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Product and Services
7.15.4 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Recent Developments/Updates
7.15.6 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Competitive Strengths & Weaknesses
7.16 Tianjin Ruipu Biotechnology
7.16.1 Tianjin Ruipu Biotechnology Details
7.16.2 Tianjin Ruipu Biotechnology Major Business
7.16.3 Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Product and Services
7.16.4 Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 Tianjin Ruipu Biotechnology Recent Developments/Updates
7.16.6 Tianjin Ruipu Biotechnology Competitive Strengths & Weaknesses
7.17 Kyoto Biken Laboratories
7.17.1 Kyoto Biken Laboratories Details
7.17.2 Kyoto Biken Laboratories Major Business
7.17.3 Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Product and Services
7.17.4 Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 Kyoto Biken Laboratories Recent Developments/Updates
7.17.6 Kyoto Biken Laboratories Competitive Strengths & Weaknesses
7.18 FATRO
7.18.1 FATRO Details
7.18.2 FATRO Major Business
7.18.3 FATRO Genetically Engineered Vector Vaccine Product and Services
7.18.4 FATRO Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.18.5 FATRO Recent Developments/Updates
7.18.6 FATRO Competitive Strengths & Weaknesses
7.19 Ceva Santй Animale
7.19.1 Ceva Santй Animale Details
7.19.2 Ceva Santй Animale Major Business
7.19.3 Ceva Santй Animale Genetically Engineered Vector Vaccine Product and Services
7.19.4 Ceva Santй Animale Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.19.5 Ceva Santй Animale Recent Developments/Updates
7.19.6 Ceva Santй Animale Competitive Strengths & Weaknesses
7.20 Pleco
7.20.1 Pleco Details
7.20.2 Pleco Major Business
7.20.3 Pleco Genetically Engineered Vector Vaccine Product and Services
7.20.4 Pleco Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.20.5 Pleco Recent Developments/Updates
7.20.6 Pleco Competitive Strengths & Weaknesses
7.21 Wuhan Huisheng Biotechnology
7.21.1 Wuhan Huisheng Biotechnology Details
7.21.2 Wuhan Huisheng Biotechnology Major Business
7.21.3 Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Product and Services
7.21.4 Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.21.5 Wuhan Huisheng Biotechnology Recent Developments/Updates
7.21.6 Wuhan Huisheng Biotechnology Competitive Strengths & Weaknesses
7.22 Jinhe Biotechnology
7.22.1 Jinhe Biotechnology Details
7.22.2 Jinhe Biotechnology Major Business
7.22.3 Jinhe Biotechnology Genetically Engineered Vector Vaccine Product and Services
7.22.4 Jinhe Biotechnology Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.22.5 Jinhe Biotechnology Recent Developments/Updates
7.22.6 Jinhe Biotechnology Competitive Strengths & Weaknesses
7.23 Shenlian Biotechnology
7.23.1 Shenlian Biotechnology Details
7.23.2 Shenlian Biotechnology Major Business
7.23.3 Shenlian Biotechnology Genetically Engineered Vector Vaccine Product and Services
7.23.4 Shenlian Biotechnology Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.23.5 Shenlian Biotechnology Recent Developments/Updates
7.23.6 Shenlian Biotechnology Competitive Strengths & Weaknesses
7.24 Azure Creatures
7.24.1 Azure Creatures Details
7.24.2 Azure Creatures Major Business
7.24.3 Azure Creatures Genetically Engineered Vector Vaccine Product and Services
7.24.4 Azure Creatures Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.24.5 Azure Creatures Recent Developments/Updates
7.24.6 Azure Creatures Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Genetically Engineered Vector Vaccine Industry Chain
8.2 Genetically Engineered Vector Vaccine Upstream Analysis
8.2.1 Genetically Engineered Vector Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Genetically Engineered Vector Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Genetically Engineered Vector Vaccine Production Mode
8.6 Genetically Engineered Vector Vaccine Procurement Model
8.7 Genetically Engineered Vector Vaccine Industry Sales Model and Sales Channels
8.7.1 Genetically Engineered Vector Vaccine Sales Model
8.7.2 Genetically Engineered Vector Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Genetically Engineered Vector Vaccine Introduction
1.2 World Genetically Engineered Vector Vaccine Supply & Forecast
1.2.1 World Genetically Engineered Vector Vaccine Production Value (2019 & 2023 & 2030)
1.2.2 World Genetically Engineered Vector Vaccine Production (2019-2030)
1.2.3 World Genetically Engineered Vector Vaccine Pricing Trends (2019-2030)
1.3 World Genetically Engineered Vector Vaccine Production by Region (Based on Production Site)
1.3.1 World Genetically Engineered Vector Vaccine Production Value by Region (2019-2030)
1.3.2 World Genetically Engineered Vector Vaccine Production by Region (2019-2030)
1.3.3 World Genetically Engineered Vector Vaccine Average Price by Region (2019-2030)
1.3.4 North America Genetically Engineered Vector Vaccine Production (2019-2030)
1.3.5 Europe Genetically Engineered Vector Vaccine Production (2019-2030)
1.3.6 China Genetically Engineered Vector Vaccine Production (2019-2030)
1.3.7 Japan Genetically Engineered Vector Vaccine Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Genetically Engineered Vector Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Genetically Engineered Vector Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Genetically Engineered Vector Vaccine Demand (2019-2030)
2.2 World Genetically Engineered Vector Vaccine Consumption by Region
2.2.1 World Genetically Engineered Vector Vaccine Consumption by Region (2019-2024)
2.2.2 World Genetically Engineered Vector Vaccine Consumption Forecast by Region (2025-2030)
2.3 United States Genetically Engineered Vector Vaccine Consumption (2019-2030)
2.4 China Genetically Engineered Vector Vaccine Consumption (2019-2030)
2.5 Europe Genetically Engineered Vector Vaccine Consumption (2019-2030)
2.6 Japan Genetically Engineered Vector Vaccine Consumption (2019-2030)
2.7 South Korea Genetically Engineered Vector Vaccine Consumption (2019-2030)
2.8 ASEAN Genetically Engineered Vector Vaccine Consumption (2019-2030)
2.9 India Genetically Engineered Vector Vaccine Consumption (2019-2030)
3 WORLD GENETICALLY ENGINEERED VECTOR VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Genetically Engineered Vector Vaccine Production Value by Manufacturer (2019-2024)
3.2 World Genetically Engineered Vector Vaccine Production by Manufacturer (2019-2024)
3.3 World Genetically Engineered Vector Vaccine Average Price by Manufacturer (2019-2024)
3.4 Genetically Engineered Vector Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Genetically Engineered Vector Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Genetically Engineered Vector Vaccine in 2023
3.5.3 Global Concentration Ratios (CR8) for Genetically Engineered Vector Vaccine in 2023
3.6 Genetically Engineered Vector Vaccine Market: Overall Company Footprint Analysis
3.6.1 Genetically Engineered Vector Vaccine Market: Region Footprint
3.6.2 Genetically Engineered Vector Vaccine Market: Company Product Type Footprint
3.6.3 Genetically Engineered Vector Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Genetically Engineered Vector Vaccine Production Value Comparison
4.1.1 United States VS China: Genetically Engineered Vector Vaccine Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Genetically Engineered Vector Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Genetically Engineered Vector Vaccine Production Comparison
4.2.1 United States VS China: Genetically Engineered Vector Vaccine Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Genetically Engineered Vector Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Genetically Engineered Vector Vaccine Consumption Comparison
4.3.1 United States VS China: Genetically Engineered Vector Vaccine Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Genetically Engineered Vector Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Genetically Engineered Vector Vaccine Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Genetically Engineered Vector Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Genetically Engineered Vector Vaccine Production Value (2019-2024)
4.4.3 United States Based Manufacturers Genetically Engineered Vector Vaccine Production (2019-2024)
4.5 China Based Genetically Engineered Vector Vaccine Manufacturers and Market Share
4.5.1 China Based Genetically Engineered Vector Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Genetically Engineered Vector Vaccine Production Value (2019-2024)
4.5.3 China Based Manufacturers Genetically Engineered Vector Vaccine Production (2019-2024)
4.6 Rest of World Based Genetically Engineered Vector Vaccine Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Genetically Engineered Vector Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Genetically Engineered Vector Vaccine Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Genetically Engineered Vector Vaccine Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Genetically Engineered Vector Vaccine Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Viral Vector Vaccine
5.2.2 Plasmid Vector Vaccine
5.2.3 VLPV
5.2.4 RNA Vaccine
5.3 Market Segment by Type
5.3.1 World Genetically Engineered Vector Vaccine Production by Type (2019-2030)
5.3.2 World Genetically Engineered Vector Vaccine Production Value by Type (2019-2030)
5.3.3 World Genetically Engineered Vector Vaccine Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Genetically Engineered Vector Vaccine Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Genetically Engineered Vector Vaccine Production by Application (2019-2030)
6.3.2 World Genetically Engineered Vector Vaccine Production Value by Application (2019-2030)
6.3.3 World Genetically Engineered Vector Vaccine Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Genetically Engineered Vector Vaccine Product and Services
7.1.4 Pfizer Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck Genetically Engineered Vector Vaccine Product and Services
7.2.4 Merck Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Genetically Engineered Vector Vaccine Product and Services
7.3.4 GSK Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Wantai Biotechnology
7.4.1 Wantai Biotechnology Details
7.4.2 Wantai Biotechnology Major Business
7.4.3 Wantai Biotechnology Genetically Engineered Vector Vaccine Product and Services
7.4.4 Wantai Biotechnology Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Wantai Biotechnology Recent Developments/Updates
7.4.6 Wantai Biotechnology Competitive Strengths & Weaknesses
7.5 Watson Bio
7.5.1 Watson Bio Details
7.5.2 Watson Bio Major Business
7.5.3 Watson Bio Genetically Engineered Vector Vaccine Product and Services
7.5.4 Watson Bio Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Watson Bio Recent Developments/Updates
7.5.6 Watson Bio Competitive Strengths & Weaknesses
7.6 Bharat Biotech
7.6.1 Bharat Biotech Details
7.6.2 Bharat Biotech Major Business
7.6.3 Bharat Biotech Genetically Engineered Vector Vaccine Product and Services
7.6.4 Bharat Biotech Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Bharat Biotech Recent Developments/Updates
7.6.6 Bharat Biotech Competitive Strengths & Weaknesses
7.7 Sanofi
7.7.1 Sanofi Details
7.7.2 Sanofi Major Business
7.7.3 Sanofi Genetically Engineered Vector Vaccine Product and Services
7.7.4 Sanofi Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Sanofi Recent Developments/Updates
7.7.6 Sanofi Competitive Strengths & Weaknesses
7.8 Zoties
7.8.1 Zoties Details
7.8.2 Zoties Major Business
7.8.3 Zoties Genetically Engineered Vector Vaccine Product and Services
7.8.4 Zoties Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Zoties Recent Developments/Updates
7.8.6 Zoties Competitive Strengths & Weaknesses
7.9 Elanco
7.9.1 Elanco Details
7.9.2 Elanco Major Business
7.9.3 Elanco Genetically Engineered Vector Vaccine Product and Services
7.9.4 Elanco Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Elanco Recent Developments/Updates
7.9.6 Elanco Competitive Strengths & Weaknesses
7.10 Boehringer Ingelheim
7.10.1 Boehringer Ingelheim Details
7.10.2 Boehringer Ingelheim Major Business
7.10.3 Boehringer Ingelheim Genetically Engineered Vector Vaccine Product and Services
7.10.4 Boehringer Ingelheim Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Boehringer Ingelheim Recent Developments/Updates
7.10.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.11 Indian Immunologicals
7.11.1 Indian Immunologicals Details
7.11.2 Indian Immunologicals Major Business
7.11.3 Indian Immunologicals Genetically Engineered Vector Vaccine Product and Services
7.11.4 Indian Immunologicals Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Indian Immunologicals Recent Developments/Updates
7.11.6 Indian Immunologicals Competitive Strengths & Weaknesses
7.12 Zhongmu Industrial Co., Ltd.
7.12.1 Zhongmu Industrial Co., Ltd. Details
7.12.2 Zhongmu Industrial Co., Ltd. Major Business
7.12.3 Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Product and Services
7.12.4 Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Zhongmu Industrial Co., Ltd. Recent Developments/Updates
7.12.6 Zhongmu Industrial Co., Ltd. Competitive Strengths & Weaknesses
7.13 Qingdao Yibang Bioengineering Co., Ltd.
7.13.1 Qingdao Yibang Bioengineering Co., Ltd. Details
7.13.2 Qingdao Yibang Bioengineering Co., Ltd. Major Business
7.13.3 Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Product and Services
7.13.4 Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Qingdao Yibang Bioengineering Co., Ltd. Recent Developments/Updates
7.13.6 Qingdao Yibang Bioengineering Co., Ltd. Competitive Strengths & Weaknesses
7.14 Jinyu Biotechnology
7.14.1 Jinyu Biotechnology Details
7.14.2 Jinyu Biotechnology Major Business
7.14.3 Jinyu Biotechnology Genetically Engineered Vector Vaccine Product and Services
7.14.4 Jinyu Biotechnology Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Jinyu Biotechnology Recent Developments/Updates
7.14.6 Jinyu Biotechnology Competitive Strengths & Weaknesses
7.15 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences
7.15.1 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Details
7.15.2 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Major Business
7.15.3 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Product and Services
7.15.4 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Recent Developments/Updates
7.15.6 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Competitive Strengths & Weaknesses
7.16 Tianjin Ruipu Biotechnology
7.16.1 Tianjin Ruipu Biotechnology Details
7.16.2 Tianjin Ruipu Biotechnology Major Business
7.16.3 Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Product and Services
7.16.4 Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 Tianjin Ruipu Biotechnology Recent Developments/Updates
7.16.6 Tianjin Ruipu Biotechnology Competitive Strengths & Weaknesses
7.17 Kyoto Biken Laboratories
7.17.1 Kyoto Biken Laboratories Details
7.17.2 Kyoto Biken Laboratories Major Business
7.17.3 Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Product and Services
7.17.4 Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 Kyoto Biken Laboratories Recent Developments/Updates
7.17.6 Kyoto Biken Laboratories Competitive Strengths & Weaknesses
7.18 FATRO
7.18.1 FATRO Details
7.18.2 FATRO Major Business
7.18.3 FATRO Genetically Engineered Vector Vaccine Product and Services
7.18.4 FATRO Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.18.5 FATRO Recent Developments/Updates
7.18.6 FATRO Competitive Strengths & Weaknesses
7.19 Ceva Santй Animale
7.19.1 Ceva Santй Animale Details
7.19.2 Ceva Santй Animale Major Business
7.19.3 Ceva Santй Animale Genetically Engineered Vector Vaccine Product and Services
7.19.4 Ceva Santй Animale Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.19.5 Ceva Santй Animale Recent Developments/Updates
7.19.6 Ceva Santй Animale Competitive Strengths & Weaknesses
7.20 Pleco
7.20.1 Pleco Details
7.20.2 Pleco Major Business
7.20.3 Pleco Genetically Engineered Vector Vaccine Product and Services
7.20.4 Pleco Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.20.5 Pleco Recent Developments/Updates
7.20.6 Pleco Competitive Strengths & Weaknesses
7.21 Wuhan Huisheng Biotechnology
7.21.1 Wuhan Huisheng Biotechnology Details
7.21.2 Wuhan Huisheng Biotechnology Major Business
7.21.3 Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Product and Services
7.21.4 Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.21.5 Wuhan Huisheng Biotechnology Recent Developments/Updates
7.21.6 Wuhan Huisheng Biotechnology Competitive Strengths & Weaknesses
7.22 Jinhe Biotechnology
7.22.1 Jinhe Biotechnology Details
7.22.2 Jinhe Biotechnology Major Business
7.22.3 Jinhe Biotechnology Genetically Engineered Vector Vaccine Product and Services
7.22.4 Jinhe Biotechnology Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.22.5 Jinhe Biotechnology Recent Developments/Updates
7.22.6 Jinhe Biotechnology Competitive Strengths & Weaknesses
7.23 Shenlian Biotechnology
7.23.1 Shenlian Biotechnology Details
7.23.2 Shenlian Biotechnology Major Business
7.23.3 Shenlian Biotechnology Genetically Engineered Vector Vaccine Product and Services
7.23.4 Shenlian Biotechnology Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.23.5 Shenlian Biotechnology Recent Developments/Updates
7.23.6 Shenlian Biotechnology Competitive Strengths & Weaknesses
7.24 Azure Creatures
7.24.1 Azure Creatures Details
7.24.2 Azure Creatures Major Business
7.24.3 Azure Creatures Genetically Engineered Vector Vaccine Product and Services
7.24.4 Azure Creatures Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.24.5 Azure Creatures Recent Developments/Updates
7.24.6 Azure Creatures Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Genetically Engineered Vector Vaccine Industry Chain
8.2 Genetically Engineered Vector Vaccine Upstream Analysis
8.2.1 Genetically Engineered Vector Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Genetically Engineered Vector Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Genetically Engineered Vector Vaccine Production Mode
8.6 Genetically Engineered Vector Vaccine Procurement Model
8.7 Genetically Engineered Vector Vaccine Industry Sales Model and Sales Channels
8.7.1 Genetically Engineered Vector Vaccine Sales Model
8.7.2 Genetically Engineered Vector Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Genetically Engineered Vector Vaccine Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Genetically Engineered Vector Vaccine Production Value by Region (2019-2024) & (USD Million)
Table 3. World Genetically Engineered Vector Vaccine Production Value by Region (2025-2030) & (USD Million)
Table 4. World Genetically Engineered Vector Vaccine Production Value Market Share by Region (2019-2024)
Table 5. World Genetically Engineered Vector Vaccine Production Value Market Share by Region (2025-2030)
Table 6. World Genetically Engineered Vector Vaccine Production by Region (2019-2024) & (K Units)
Table 7. World Genetically Engineered Vector Vaccine Production by Region (2025-2030) & (K Units)
Table 8. World Genetically Engineered Vector Vaccine Production Market Share by Region (2019-2024)
Table 9. World Genetically Engineered Vector Vaccine Production Market Share by Region (2025-2030)
Table 10. World Genetically Engineered Vector Vaccine Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Genetically Engineered Vector Vaccine Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Genetically Engineered Vector Vaccine Major Market Trends
Table 13. World Genetically Engineered Vector Vaccine Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Genetically Engineered Vector Vaccine Consumption by Region (2019-2024) & (K Units)
Table 15. World Genetically Engineered Vector Vaccine Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Genetically Engineered Vector Vaccine Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Genetically Engineered Vector Vaccine Producers in 2023
Table 18. World Genetically Engineered Vector Vaccine Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Genetically Engineered Vector Vaccine Producers in 2023
Table 20. World Genetically Engineered Vector Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Genetically Engineered Vector Vaccine Company Evaluation Quadrant
Table 22. World Genetically Engineered Vector Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Genetically Engineered Vector Vaccine Production Site of Key Manufacturer
Table 24. Genetically Engineered Vector Vaccine Market: Company Product Type Footprint
Table 25. Genetically Engineered Vector Vaccine Market: Company Product Application Footprint
Table 26. Genetically Engineered Vector Vaccine Competitive Factors
Table 27. Genetically Engineered Vector Vaccine New Entrant and Capacity Expansion Plans
Table 28. Genetically Engineered Vector Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Genetically Engineered Vector Vaccine Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Genetically Engineered Vector Vaccine Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Genetically Engineered Vector Vaccine Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Genetically Engineered Vector Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Genetically Engineered Vector Vaccine Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Genetically Engineered Vector Vaccine Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Genetically Engineered Vector Vaccine Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Genetically Engineered Vector Vaccine Production Market Share (2019-2024)
Table 37. China Based Genetically Engineered Vector Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Genetically Engineered Vector Vaccine Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Genetically Engineered Vector Vaccine Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Genetically Engineered Vector Vaccine Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Genetically Engineered Vector Vaccine Production Market Share (2019-2024)
Table 42. Rest of World Based Genetically Engineered Vector Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Genetically Engineered Vector Vaccine Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Genetically Engineered Vector Vaccine Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Genetically Engineered Vector Vaccine Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Genetically Engineered Vector Vaccine Production Market Share (2019-2024)
Table 47. World Genetically Engineered Vector Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Genetically Engineered Vector Vaccine Production by Type (2019-2024) & (K Units)
Table 49. World Genetically Engineered Vector Vaccine Production by Type (2025-2030) & (K Units)
Table 50. World Genetically Engineered Vector Vaccine Production Value by Type (2019-2024) & (USD Million)
Table 51. World Genetically Engineered Vector Vaccine Production Value by Type (2025-2030) & (USD Million)
Table 52. World Genetically Engineered Vector Vaccine Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Genetically Engineered Vector Vaccine Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Genetically Engineered Vector Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Genetically Engineered Vector Vaccine Production by Application (2019-2024) & (K Units)
Table 56. World Genetically Engineered Vector Vaccine Production by Application (2025-2030) & (K Units)
Table 57. World Genetically Engineered Vector Vaccine Production Value by Application (2019-2024) & (USD Million)
Table 58. World Genetically Engineered Vector Vaccine Production Value by Application (2025-2030) & (USD Million)
Table 59. World Genetically Engineered Vector Vaccine Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Genetically Engineered Vector Vaccine Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Genetically Engineered Vector Vaccine Product and Services
Table 64. Pfizer Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Merck Basic Information, Manufacturing Base and Competitors
Table 68. Merck Major Business
Table 69. Merck Genetically Engineered Vector Vaccine Product and Services
Table 70. Merck Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Merck Recent Developments/Updates
Table 72. Merck Competitive Strengths & Weaknesses
Table 73. GSK Basic Information, Manufacturing Base and Competitors
Table 74. GSK Major Business
Table 75. GSK Genetically Engineered Vector Vaccine Product and Services
Table 76. GSK Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. GSK Recent Developments/Updates
Table 78. GSK Competitive Strengths & Weaknesses
Table 79. Wantai Biotechnology Basic Information, Manufacturing Base and Competitors
Table 80. Wantai Biotechnology Major Business
Table 81. Wantai Biotechnology Genetically Engineered Vector Vaccine Product and Services
Table 82. Wantai Biotechnology Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Wantai Biotechnology Recent Developments/Updates
Table 84. Wantai Biotechnology Competitive Strengths & Weaknesses
Table 85. Watson Bio Basic Information, Manufacturing Base and Competitors
Table 86. Watson Bio Major Business
Table 87. Watson Bio Genetically Engineered Vector Vaccine Product and Services
Table 88. Watson Bio Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Watson Bio Recent Developments/Updates
Table 90. Watson Bio Competitive Strengths & Weaknesses
Table 91. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 92. Bharat Biotech Major Business
Table 93. Bharat Biotech Genetically Engineered Vector Vaccine Product and Services
Table 94. Bharat Biotech Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Bharat Biotech Recent Developments/Updates
Table 96. Bharat Biotech Competitive Strengths & Weaknesses
Table 97. Sanofi Basic Information, Manufacturing Base and Competitors
Table 98. Sanofi Major Business
Table 99. Sanofi Genetically Engineered Vector Vaccine Product and Services
Table 100. Sanofi Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Sanofi Recent Developments/Updates
Table 102. Sanofi Competitive Strengths & Weaknesses
Table 103. Zoties Basic Information, Manufacturing Base and Competitors
Table 104. Zoties Major Business
Table 105. Zoties Genetically Engineered Vector Vaccine Product and Services
Table 106. Zoties Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Zoties Recent Developments/Updates
Table 108. Zoties Competitive Strengths & Weaknesses
Table 109. Elanco Basic Information, Manufacturing Base and Competitors
Table 110. Elanco Major Business
Table 111. Elanco Genetically Engineered Vector Vaccine Product and Services
Table 112. Elanco Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Elanco Recent Developments/Updates
Table 114. Elanco Competitive Strengths & Weaknesses
Table 115. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 116. Boehringer Ingelheim Major Business
Table 117. Boehringer Ingelheim Genetically Engineered Vector Vaccine Product and Services
Table 118. Boehringer Ingelheim Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Boehringer Ingelheim Recent Developments/Updates
Table 120. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 121. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 122. Indian Immunologicals Major Business
Table 123. Indian Immunologicals Genetically Engineered Vector Vaccine Product and Services
Table 124. Indian Immunologicals Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Indian Immunologicals Recent Developments/Updates
Table 126. Indian Immunologicals Competitive Strengths & Weaknesses
Table 127. Zhongmu Industrial Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 128. Zhongmu Industrial Co., Ltd. Major Business
Table 129. Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Product and Services
Table 130. Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Zhongmu Industrial Co., Ltd. Recent Developments/Updates
Table 132. Zhongmu Industrial Co., Ltd. Competitive Strengths & Weaknesses
Table 133. Qingdao Yibang Bioengineering Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 134. Qingdao Yibang Bioengineering Co., Ltd. Major Business
Table 135. Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Product and Services
Table 136. Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Qingdao Yibang Bioengineering Co., Ltd. Recent Developments/Updates
Table 138. Qingdao Yibang Bioengineering Co., Ltd. Competitive Strengths & Weaknesses
Table 139. Jinyu Biotechnology Basic Information, Manufacturing Base and Competitors
Table 140. Jinyu Biotechnology Major Business
Table 141. Jinyu Biotechnology Genetically Engineered Vector Vaccine Product and Services
Table 142. Jinyu Biotechnology Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Jinyu Biotechnology Recent Developments/Updates
Table 144. Jinyu Biotechnology Competitive Strengths & Weaknesses
Table 145. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Basic Information, Manufacturing Base and Competitors
Table 146. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Major Business
Table 147. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Product and Services
Table 148. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Recent Developments/Updates
Table 150. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Competitive Strengths & Weaknesses
Table 151. Tianjin Ruipu Biotechnology Basic Information, Manufacturing Base and Competitors
Table 152. Tianjin Ruipu Biotechnology Major Business
Table 153. Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Product and Services
Table 154. Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. Tianjin Ruipu Biotechnology Recent Developments/Updates
Table 156. Tianjin Ruipu Biotechnology Competitive Strengths & Weaknesses
Table 157. Kyoto Biken Laboratories Basic Information, Manufacturing Base and Competitors
Table 158. Kyoto Biken Laboratories Major Business
Table 159. Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Product and Services
Table 160. Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 161. Kyoto Biken Laboratories Recent Developments/Updates
Table 162. Kyoto Biken Laboratories Competitive Strengths & Weaknesses
Table 163. FATRO Basic Information, Manufacturing Base and Competitors
Table 164. FATRO Major Business
Table 165. FATRO Genetically Engineered Vector Vaccine Product and Services
Table 166. FATRO Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 167. FATRO Recent Developments/Updates
Table 168. FATRO Competitive Strengths & Weaknesses
Table 169. Ceva Santй Animale Basic Information, Manufacturing Base and Competitors
Table 170. Ceva Santй Animale Major Business
Table 171. Ceva Santй Animale Genetically Engineered Vector Vaccine Product and Services
Table 172. Ceva Santй Animale Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 173. Ceva Santй Animale Recent Developments/Updates
Table 174. Ceva Santй Animale Competitive Strengths & Weaknesses
Table 175. Pleco Basic Information, Manufacturing Base and Competitors
Table 176. Pleco Major Business
Table 177. Pleco Genetically Engineered Vector Vaccine Product and Services
Table 178. Pleco Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 179. Pleco Recent Developments/Updates
Table 180. Pleco Competitive Strengths & Weaknesses
Table 181. Wuhan Huisheng Biotechnology Basic Information, Manufacturing Base and Competitors
Table 182. Wuhan Huisheng Biotechnology Major Business
Table 183. Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Product and Services
Table 184. Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 185. Wuhan Huisheng Biotechnology Recent Developments/Updates
Table 186. Wuhan Huisheng Biotechnology Competitive Strengths & Weaknesses
Table 187. Jinhe Biotechnology Basic Information, Manufacturing Base and Competitors
Table 188. Jinhe Biotechnology Major Business
Table 189. Jinhe Biotechnology Genetically Engineered Vector Vaccine Product and Services
Table 190. Jinhe Biotechnology Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 191. Jinhe Biotechnology Recent Developments/Updates
Table 192. Jinhe Biotechnology Competitive Strengths & Weaknesses
Table 193. Shenlian Biotechnology Basic Information, Manufacturing Base and Competitors
Table 194. Shenlian Biotechnology Major Business
Table 195. Shenlian Biotechnology Genetically Engineered Vector Vaccine Product and Services
Table 196. Shenlian Biotechnology Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 197. Shenlian Biotechnology Recent Developments/Updates
Table 198. Azure Creatures Basic Information, Manufacturing Base and Competitors
Table 199. Azure Creatures Major Business
Table 200. Azure Creatures Genetically Engineered Vector Vaccine Product and Services
Table 201. Azure Creatures Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 202. Global Key Players of Genetically Engineered Vector Vaccine Upstream (Raw Materials)
Table 203. Genetically Engineered Vector Vaccine Typical Customers
Table 204. Genetically Engineered Vector Vaccine Typical Distributors
LIST OF FIGURE
Figure 1. Genetically Engineered Vector Vaccine Picture
Figure 2. World Genetically Engineered Vector Vaccine Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Genetically Engineered Vector Vaccine Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Genetically Engineered Vector Vaccine Production (2019-2030) & (K Units)
Figure 5. World Genetically Engineered Vector Vaccine Average Price (2019-2030) & (US$/Unit)
Figure 6. World Genetically Engineered Vector Vaccine Production Value Market Share by Region (2019-2030)
Figure 7. World Genetically Engineered Vector Vaccine Production Market Share by Region (2019-2030)
Figure 8. North America Genetically Engineered Vector Vaccine Production (2019-2030) & (K Units)
Figure 9. Europe Genetically Engineered Vector Vaccine Production (2019-2030) & (K Units)
Figure 10. China Genetically Engineered Vector Vaccine Production (2019-2030) & (K Units)
Figure 11. Japan Genetically Engineered Vector Vaccine Production (2019-2030) & (K Units)
Figure 12. Genetically Engineered Vector Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Genetically Engineered Vector Vaccine Consumption (2019-2030) & (K Units)
Figure 15. World Genetically Engineered Vector Vaccine Consumption Market Share by Region (2019-2030)
Figure 16. United States Genetically Engineered Vector Vaccine Consumption (2019-2030) & (K Units)
Figure 17. China Genetically Engineered Vector Vaccine Consumption (2019-2030) & (K Units)
Figure 18. Europe Genetically Engineered Vector Vaccine Consumption (2019-2030) & (K Units)
Figure 19. Japan Genetically Engineered Vector Vaccine Consumption (2019-2030) & (K Units)
Figure 20. South Korea Genetically Engineered Vector Vaccine Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Genetically Engineered Vector Vaccine Consumption (2019-2030) & (K Units)
Figure 22. India Genetically Engineered Vector Vaccine Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Genetically Engineered Vector Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Genetically Engineered Vector Vaccine Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Genetically Engineered Vector Vaccine Markets in 2023
Figure 26. United States VS China: Genetically Engineered Vector Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Genetically Engineered Vector Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Genetically Engineered Vector Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Genetically Engineered Vector Vaccine Production Market Share 2023
Figure 30. China Based Manufacturers Genetically Engineered Vector Vaccine Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Genetically Engineered Vector Vaccine Production Market Share 2023
Figure 32. World Genetically Engineered Vector Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Genetically Engineered Vector Vaccine Production Value Market Share by Type in 2023
Figure 34. Viral Vector Vaccine
Figure 35. Plasmid Vector Vaccine
Figure 36. VLPV
Figure 37. RNA Vaccine
Figure 38. World Genetically Engineered Vector Vaccine Production Market Share by Type (2019-2030)
Figure 39. World Genetically Engineered Vector Vaccine Production Value Market Share by Type (2019-2030)
Figure 40. World Genetically Engineered Vector Vaccine Average Price by Type (2019-2030) & (US$/Unit)
Figure 41. World Genetically Engineered Vector Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 42. World Genetically Engineered Vector Vaccine Production Value Market Share by Application in 2023
Figure 43. Hospital
Figure 44. Clinic
Figure 45. Others
Figure 46. World Genetically Engineered Vector Vaccine Production Market Share by Application (2019-2030)
Figure 47. World Genetically Engineered Vector Vaccine Production Value Market Share by Application (2019-2030)
Figure 48. World Genetically Engineered Vector Vaccine Average Price by Application (2019-2030) & (US$/Unit)
Figure 49. Genetically Engineered Vector Vaccine Industry Chain
Figure 50. Genetically Engineered Vector Vaccine Procurement Model
Figure 51. Genetically Engineered Vector Vaccine Sales Model
Figure 52. Genetically Engineered Vector Vaccine Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Table 1. World Genetically Engineered Vector Vaccine Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Genetically Engineered Vector Vaccine Production Value by Region (2019-2024) & (USD Million)
Table 3. World Genetically Engineered Vector Vaccine Production Value by Region (2025-2030) & (USD Million)
Table 4. World Genetically Engineered Vector Vaccine Production Value Market Share by Region (2019-2024)
Table 5. World Genetically Engineered Vector Vaccine Production Value Market Share by Region (2025-2030)
Table 6. World Genetically Engineered Vector Vaccine Production by Region (2019-2024) & (K Units)
Table 7. World Genetically Engineered Vector Vaccine Production by Region (2025-2030) & (K Units)
Table 8. World Genetically Engineered Vector Vaccine Production Market Share by Region (2019-2024)
Table 9. World Genetically Engineered Vector Vaccine Production Market Share by Region (2025-2030)
Table 10. World Genetically Engineered Vector Vaccine Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Genetically Engineered Vector Vaccine Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Genetically Engineered Vector Vaccine Major Market Trends
Table 13. World Genetically Engineered Vector Vaccine Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Genetically Engineered Vector Vaccine Consumption by Region (2019-2024) & (K Units)
Table 15. World Genetically Engineered Vector Vaccine Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Genetically Engineered Vector Vaccine Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Genetically Engineered Vector Vaccine Producers in 2023
Table 18. World Genetically Engineered Vector Vaccine Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Genetically Engineered Vector Vaccine Producers in 2023
Table 20. World Genetically Engineered Vector Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Genetically Engineered Vector Vaccine Company Evaluation Quadrant
Table 22. World Genetically Engineered Vector Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Genetically Engineered Vector Vaccine Production Site of Key Manufacturer
Table 24. Genetically Engineered Vector Vaccine Market: Company Product Type Footprint
Table 25. Genetically Engineered Vector Vaccine Market: Company Product Application Footprint
Table 26. Genetically Engineered Vector Vaccine Competitive Factors
Table 27. Genetically Engineered Vector Vaccine New Entrant and Capacity Expansion Plans
Table 28. Genetically Engineered Vector Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Genetically Engineered Vector Vaccine Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Genetically Engineered Vector Vaccine Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Genetically Engineered Vector Vaccine Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Genetically Engineered Vector Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Genetically Engineered Vector Vaccine Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Genetically Engineered Vector Vaccine Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Genetically Engineered Vector Vaccine Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Genetically Engineered Vector Vaccine Production Market Share (2019-2024)
Table 37. China Based Genetically Engineered Vector Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Genetically Engineered Vector Vaccine Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Genetically Engineered Vector Vaccine Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Genetically Engineered Vector Vaccine Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Genetically Engineered Vector Vaccine Production Market Share (2019-2024)
Table 42. Rest of World Based Genetically Engineered Vector Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Genetically Engineered Vector Vaccine Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Genetically Engineered Vector Vaccine Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Genetically Engineered Vector Vaccine Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Genetically Engineered Vector Vaccine Production Market Share (2019-2024)
Table 47. World Genetically Engineered Vector Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Genetically Engineered Vector Vaccine Production by Type (2019-2024) & (K Units)
Table 49. World Genetically Engineered Vector Vaccine Production by Type (2025-2030) & (K Units)
Table 50. World Genetically Engineered Vector Vaccine Production Value by Type (2019-2024) & (USD Million)
Table 51. World Genetically Engineered Vector Vaccine Production Value by Type (2025-2030) & (USD Million)
Table 52. World Genetically Engineered Vector Vaccine Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Genetically Engineered Vector Vaccine Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Genetically Engineered Vector Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Genetically Engineered Vector Vaccine Production by Application (2019-2024) & (K Units)
Table 56. World Genetically Engineered Vector Vaccine Production by Application (2025-2030) & (K Units)
Table 57. World Genetically Engineered Vector Vaccine Production Value by Application (2019-2024) & (USD Million)
Table 58. World Genetically Engineered Vector Vaccine Production Value by Application (2025-2030) & (USD Million)
Table 59. World Genetically Engineered Vector Vaccine Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Genetically Engineered Vector Vaccine Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Genetically Engineered Vector Vaccine Product and Services
Table 64. Pfizer Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Merck Basic Information, Manufacturing Base and Competitors
Table 68. Merck Major Business
Table 69. Merck Genetically Engineered Vector Vaccine Product and Services
Table 70. Merck Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Merck Recent Developments/Updates
Table 72. Merck Competitive Strengths & Weaknesses
Table 73. GSK Basic Information, Manufacturing Base and Competitors
Table 74. GSK Major Business
Table 75. GSK Genetically Engineered Vector Vaccine Product and Services
Table 76. GSK Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. GSK Recent Developments/Updates
Table 78. GSK Competitive Strengths & Weaknesses
Table 79. Wantai Biotechnology Basic Information, Manufacturing Base and Competitors
Table 80. Wantai Biotechnology Major Business
Table 81. Wantai Biotechnology Genetically Engineered Vector Vaccine Product and Services
Table 82. Wantai Biotechnology Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Wantai Biotechnology Recent Developments/Updates
Table 84. Wantai Biotechnology Competitive Strengths & Weaknesses
Table 85. Watson Bio Basic Information, Manufacturing Base and Competitors
Table 86. Watson Bio Major Business
Table 87. Watson Bio Genetically Engineered Vector Vaccine Product and Services
Table 88. Watson Bio Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Watson Bio Recent Developments/Updates
Table 90. Watson Bio Competitive Strengths & Weaknesses
Table 91. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 92. Bharat Biotech Major Business
Table 93. Bharat Biotech Genetically Engineered Vector Vaccine Product and Services
Table 94. Bharat Biotech Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Bharat Biotech Recent Developments/Updates
Table 96. Bharat Biotech Competitive Strengths & Weaknesses
Table 97. Sanofi Basic Information, Manufacturing Base and Competitors
Table 98. Sanofi Major Business
Table 99. Sanofi Genetically Engineered Vector Vaccine Product and Services
Table 100. Sanofi Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Sanofi Recent Developments/Updates
Table 102. Sanofi Competitive Strengths & Weaknesses
Table 103. Zoties Basic Information, Manufacturing Base and Competitors
Table 104. Zoties Major Business
Table 105. Zoties Genetically Engineered Vector Vaccine Product and Services
Table 106. Zoties Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Zoties Recent Developments/Updates
Table 108. Zoties Competitive Strengths & Weaknesses
Table 109. Elanco Basic Information, Manufacturing Base and Competitors
Table 110. Elanco Major Business
Table 111. Elanco Genetically Engineered Vector Vaccine Product and Services
Table 112. Elanco Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Elanco Recent Developments/Updates
Table 114. Elanco Competitive Strengths & Weaknesses
Table 115. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 116. Boehringer Ingelheim Major Business
Table 117. Boehringer Ingelheim Genetically Engineered Vector Vaccine Product and Services
Table 118. Boehringer Ingelheim Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Boehringer Ingelheim Recent Developments/Updates
Table 120. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 121. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 122. Indian Immunologicals Major Business
Table 123. Indian Immunologicals Genetically Engineered Vector Vaccine Product and Services
Table 124. Indian Immunologicals Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Indian Immunologicals Recent Developments/Updates
Table 126. Indian Immunologicals Competitive Strengths & Weaknesses
Table 127. Zhongmu Industrial Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 128. Zhongmu Industrial Co., Ltd. Major Business
Table 129. Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Product and Services
Table 130. Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Zhongmu Industrial Co., Ltd. Recent Developments/Updates
Table 132. Zhongmu Industrial Co., Ltd. Competitive Strengths & Weaknesses
Table 133. Qingdao Yibang Bioengineering Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 134. Qingdao Yibang Bioengineering Co., Ltd. Major Business
Table 135. Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Product and Services
Table 136. Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Qingdao Yibang Bioengineering Co., Ltd. Recent Developments/Updates
Table 138. Qingdao Yibang Bioengineering Co., Ltd. Competitive Strengths & Weaknesses
Table 139. Jinyu Biotechnology Basic Information, Manufacturing Base and Competitors
Table 140. Jinyu Biotechnology Major Business
Table 141. Jinyu Biotechnology Genetically Engineered Vector Vaccine Product and Services
Table 142. Jinyu Biotechnology Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Jinyu Biotechnology Recent Developments/Updates
Table 144. Jinyu Biotechnology Competitive Strengths & Weaknesses
Table 145. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Basic Information, Manufacturing Base and Competitors
Table 146. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Major Business
Table 147. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Product and Services
Table 148. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Recent Developments/Updates
Table 150. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Competitive Strengths & Weaknesses
Table 151. Tianjin Ruipu Biotechnology Basic Information, Manufacturing Base and Competitors
Table 152. Tianjin Ruipu Biotechnology Major Business
Table 153. Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Product and Services
Table 154. Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. Tianjin Ruipu Biotechnology Recent Developments/Updates
Table 156. Tianjin Ruipu Biotechnology Competitive Strengths & Weaknesses
Table 157. Kyoto Biken Laboratories Basic Information, Manufacturing Base and Competitors
Table 158. Kyoto Biken Laboratories Major Business
Table 159. Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Product and Services
Table 160. Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 161. Kyoto Biken Laboratories Recent Developments/Updates
Table 162. Kyoto Biken Laboratories Competitive Strengths & Weaknesses
Table 163. FATRO Basic Information, Manufacturing Base and Competitors
Table 164. FATRO Major Business
Table 165. FATRO Genetically Engineered Vector Vaccine Product and Services
Table 166. FATRO Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 167. FATRO Recent Developments/Updates
Table 168. FATRO Competitive Strengths & Weaknesses
Table 169. Ceva Santй Animale Basic Information, Manufacturing Base and Competitors
Table 170. Ceva Santй Animale Major Business
Table 171. Ceva Santй Animale Genetically Engineered Vector Vaccine Product and Services
Table 172. Ceva Santй Animale Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 173. Ceva Santй Animale Recent Developments/Updates
Table 174. Ceva Santй Animale Competitive Strengths & Weaknesses
Table 175. Pleco Basic Information, Manufacturing Base and Competitors
Table 176. Pleco Major Business
Table 177. Pleco Genetically Engineered Vector Vaccine Product and Services
Table 178. Pleco Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 179. Pleco Recent Developments/Updates
Table 180. Pleco Competitive Strengths & Weaknesses
Table 181. Wuhan Huisheng Biotechnology Basic Information, Manufacturing Base and Competitors
Table 182. Wuhan Huisheng Biotechnology Major Business
Table 183. Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Product and Services
Table 184. Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 185. Wuhan Huisheng Biotechnology Recent Developments/Updates
Table 186. Wuhan Huisheng Biotechnology Competitive Strengths & Weaknesses
Table 187. Jinhe Biotechnology Basic Information, Manufacturing Base and Competitors
Table 188. Jinhe Biotechnology Major Business
Table 189. Jinhe Biotechnology Genetically Engineered Vector Vaccine Product and Services
Table 190. Jinhe Biotechnology Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 191. Jinhe Biotechnology Recent Developments/Updates
Table 192. Jinhe Biotechnology Competitive Strengths & Weaknesses
Table 193. Shenlian Biotechnology Basic Information, Manufacturing Base and Competitors
Table 194. Shenlian Biotechnology Major Business
Table 195. Shenlian Biotechnology Genetically Engineered Vector Vaccine Product and Services
Table 196. Shenlian Biotechnology Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 197. Shenlian Biotechnology Recent Developments/Updates
Table 198. Azure Creatures Basic Information, Manufacturing Base and Competitors
Table 199. Azure Creatures Major Business
Table 200. Azure Creatures Genetically Engineered Vector Vaccine Product and Services
Table 201. Azure Creatures Genetically Engineered Vector Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 202. Global Key Players of Genetically Engineered Vector Vaccine Upstream (Raw Materials)
Table 203. Genetically Engineered Vector Vaccine Typical Customers
Table 204. Genetically Engineered Vector Vaccine Typical Distributors
LIST OF FIGURE
Figure 1. Genetically Engineered Vector Vaccine Picture
Figure 2. World Genetically Engineered Vector Vaccine Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Genetically Engineered Vector Vaccine Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Genetically Engineered Vector Vaccine Production (2019-2030) & (K Units)
Figure 5. World Genetically Engineered Vector Vaccine Average Price (2019-2030) & (US$/Unit)
Figure 6. World Genetically Engineered Vector Vaccine Production Value Market Share by Region (2019-2030)
Figure 7. World Genetically Engineered Vector Vaccine Production Market Share by Region (2019-2030)
Figure 8. North America Genetically Engineered Vector Vaccine Production (2019-2030) & (K Units)
Figure 9. Europe Genetically Engineered Vector Vaccine Production (2019-2030) & (K Units)
Figure 10. China Genetically Engineered Vector Vaccine Production (2019-2030) & (K Units)
Figure 11. Japan Genetically Engineered Vector Vaccine Production (2019-2030) & (K Units)
Figure 12. Genetically Engineered Vector Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Genetically Engineered Vector Vaccine Consumption (2019-2030) & (K Units)
Figure 15. World Genetically Engineered Vector Vaccine Consumption Market Share by Region (2019-2030)
Figure 16. United States Genetically Engineered Vector Vaccine Consumption (2019-2030) & (K Units)
Figure 17. China Genetically Engineered Vector Vaccine Consumption (2019-2030) & (K Units)
Figure 18. Europe Genetically Engineered Vector Vaccine Consumption (2019-2030) & (K Units)
Figure 19. Japan Genetically Engineered Vector Vaccine Consumption (2019-2030) & (K Units)
Figure 20. South Korea Genetically Engineered Vector Vaccine Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Genetically Engineered Vector Vaccine Consumption (2019-2030) & (K Units)
Figure 22. India Genetically Engineered Vector Vaccine Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Genetically Engineered Vector Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Genetically Engineered Vector Vaccine Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Genetically Engineered Vector Vaccine Markets in 2023
Figure 26. United States VS China: Genetically Engineered Vector Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Genetically Engineered Vector Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Genetically Engineered Vector Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Genetically Engineered Vector Vaccine Production Market Share 2023
Figure 30. China Based Manufacturers Genetically Engineered Vector Vaccine Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Genetically Engineered Vector Vaccine Production Market Share 2023
Figure 32. World Genetically Engineered Vector Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Genetically Engineered Vector Vaccine Production Value Market Share by Type in 2023
Figure 34. Viral Vector Vaccine
Figure 35. Plasmid Vector Vaccine
Figure 36. VLPV
Figure 37. RNA Vaccine
Figure 38. World Genetically Engineered Vector Vaccine Production Market Share by Type (2019-2030)
Figure 39. World Genetically Engineered Vector Vaccine Production Value Market Share by Type (2019-2030)
Figure 40. World Genetically Engineered Vector Vaccine Average Price by Type (2019-2030) & (US$/Unit)
Figure 41. World Genetically Engineered Vector Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 42. World Genetically Engineered Vector Vaccine Production Value Market Share by Application in 2023
Figure 43. Hospital
Figure 44. Clinic
Figure 45. Others
Figure 46. World Genetically Engineered Vector Vaccine Production Market Share by Application (2019-2030)
Figure 47. World Genetically Engineered Vector Vaccine Production Value Market Share by Application (2019-2030)
Figure 48. World Genetically Engineered Vector Vaccine Average Price by Application (2019-2030) & (US$/Unit)
Figure 49. Genetically Engineered Vector Vaccine Industry Chain
Figure 50. Genetically Engineered Vector Vaccine Procurement Model
Figure 51. Genetically Engineered Vector Vaccine Sales Model
Figure 52. Genetically Engineered Vector Vaccine Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
